Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41
about
Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based ConstructsAlternate serotype adenovector provides long-term therapeutic gene expression in the eye.Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunizationPotent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28.Ocular localization and transduction by adenoviral vectors are serotype-dependent and can be modified by inclusion of RGD fiber modificationsCharacterization of human adenovirus 35 and derivation of complex vectorsCurrent progress in the development of a prophylactic vaccine for HIV-1.Oral adenoviral-based vaccines: historical perspective and future opportunity.A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell ImmunogensThe number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexesCircumventing antivector immunity by using adenovirus-infected blood cells for repeated application of adenovirus-vectored vaccines: proof of concept in rhesus macaques.Replicating and non-replicating viral vectors for vaccine developmentEnhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors.Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.Lac-regulated system for generating adenovirus 5 vaccine vectors expressing cytolytic human immunodeficiency virus 1 genes.Delivery of human immunodeficiency virus vaccine vectors to the intestine induces enhanced mucosal cellular immunityInfection kinetics of human adenovirus serotype 41 in HEK 293 cells.Adenoviral producer cellsConstruction of an infectious clone of human adenovirus type 41.Getting genetic access to natural adenovirus genomes to explore vector diversity.Coagulation factor IX mediates serotype-specific binding of species A adenoviruses to host cells.Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus.Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent.Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies.Molecular Survey of Viral and Bacterial Causes of Childhood Diarrhea in Khartoum State, Sudan.Enteric Species F Human Adenoviruses use Laminin-Binding Integrins as Co-Receptors for Infection of Ht-29 Cells.
P2860
Q26782083-11476E0F-0734-4D0F-A3E7-CD6E9D45B584Q33397385-41A60013-E363-4C80-8D93-4A13F1F5606BQ33558605-691B400E-EBF5-413D-818A-FC76A5CF16C6Q34081164-992FCC47-EDB3-49CA-A472-3786057C4FC2Q34215308-A6A15E88-5A2A-4005-B021-DA1A975F1E2DQ34322336-82581DA0-BE49-47F5-B4E9-A108438D9CFAQ34502108-FBF91901-59A7-417B-97C6-0CD55BCCFDB6Q34746476-A821FFEC-B9AF-4F5B-9506-8654EC3B4B62Q35914367-DC996A08-05E3-4781-9B84-6904459CE98FQ36023055-12E87832-FD73-440A-8B78-DA7DE6BDF5A3Q36276187-2CAFE10A-C3EA-4892-9F94-B0F18D0407BAQ36464587-557AA1DF-3EC8-45C3-8653-042924365F8DQ37033283-EC7D63C1-5940-4135-BC71-844BDFBE87D5Q37123522-BA95BA60-41FA-4E8C-B15B-DCCE55ACE9C5Q37245921-99398049-BEAA-4447-94B4-46073455A5A9Q37247948-7E4F75AA-88F3-47FE-B55F-F010040FDD44Q37612896-FC23F687-A7BE-4AF7-9B8B-9268437CF87DQ37945217-77FEAAB2-8A14-49A5-8684-67A6F1939C63Q39360198-77B9438B-A93B-4290-A50C-C80FCD5300DFQ39437315-0ECD17E9-B42C-4125-9477-F0B5E536560FQ39462577-05E37AEC-71F1-4428-9582-5210E1F38E89Q41242033-9D935B54-D816-4FFD-B38F-A812030EF574Q45875332-A0870AB9-0191-478A-8C56-B9FF3C52069BQ45876668-E020CEC8-1B1E-4924-A75F-991AC6F7686FQ52682322-90B74575-9920-4A4E-82FC-B437F32CA0E0Q55665997-1D5341C2-5595-4672-BD99-F655F07A2854
P2860
Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41
@en
type
label
Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41
@en
prefLabel
Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41
@en
P2093
P2860
P1433
P1476
Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41
@en
P2093
C Richter King
Douglas E Brough
Franck Lemiale
Hedi Haddada
Jason G D Gall
P2860
P304
P356
10.1016/J.VACCINE.2006.11.025
P407
P50
P577
2006-11-28T00:00:00Z